Previous Close | 64.20 |
Open | 64.05 |
Bid | 64.39 x 800 |
Ask | 64.28 x 800 |
Day's Range | 63.73 - 64.44 |
52 Week Range | 49.37 - 65.87 |
Volume | |
Avg. Volume | 1,347,598 |
Market Cap | 8.669B |
Beta (5Y Monthly) | 0.94 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.96 |
Earnings Date | Apr 30, 2024 |
Forward Dividend & Yield | 0.60 (0.93%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | 74.80 |
KBR (KBR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KBR (NYSE: KBR) announced today it has been awarded a contract by SABIC Fujian Petrochemicals to license KBR's market-leading phenol technology in China.
KBR (KBR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.